LXRA haplotypes, associated with atherogenic dyslipidaemia, were not significant concerning the prevalence of CAD or myocardial infarction, but the minor allele bearers showed higher all-cause mortality than homozygotes of the major allele. This evidence concerns the gene NR1H3 and coronary artery disorder.